全文获取类型
收费全文 | 6407篇 |
免费 | 905篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 206篇 |
妇产科学 | 349篇 |
基础医学 | 758篇 |
口腔科学 | 151篇 |
临床医学 | 1400篇 |
内科学 | 1123篇 |
皮肤病学 | 82篇 |
神经病学 | 749篇 |
特种医学 | 230篇 |
外国民族医学 | 1篇 |
外科学 | 597篇 |
综合类 | 155篇 |
一般理论 | 5篇 |
预防医学 | 558篇 |
眼科学 | 166篇 |
药学 | 253篇 |
中国医学 | 40篇 |
肿瘤学 | 484篇 |
出版年
2023年 | 40篇 |
2021年 | 107篇 |
2020年 | 67篇 |
2019年 | 129篇 |
2018年 | 197篇 |
2017年 | 214篇 |
2016年 | 211篇 |
2015年 | 208篇 |
2014年 | 233篇 |
2013年 | 341篇 |
2012年 | 333篇 |
2011年 | 380篇 |
2010年 | 233篇 |
2009年 | 240篇 |
2008年 | 381篇 |
2007年 | 328篇 |
2006年 | 279篇 |
2005年 | 316篇 |
2004年 | 282篇 |
2003年 | 261篇 |
2002年 | 236篇 |
2001年 | 205篇 |
2000年 | 188篇 |
1999年 | 153篇 |
1998年 | 101篇 |
1997年 | 73篇 |
1996年 | 80篇 |
1995年 | 69篇 |
1994年 | 54篇 |
1993年 | 49篇 |
1992年 | 137篇 |
1991年 | 99篇 |
1990年 | 106篇 |
1989年 | 97篇 |
1988年 | 122篇 |
1987年 | 89篇 |
1986年 | 85篇 |
1985年 | 88篇 |
1984年 | 69篇 |
1983年 | 39篇 |
1982年 | 31篇 |
1981年 | 29篇 |
1980年 | 26篇 |
1979年 | 41篇 |
1978年 | 26篇 |
1977年 | 29篇 |
1973年 | 24篇 |
1970年 | 21篇 |
1969年 | 23篇 |
1967年 | 21篇 |
排序方式: 共有7348条查询结果,搜索用时 31 毫秒
1.
Sarah L. Spaulding BS Lauren E. Yue BA Quinn F. O'Malley BA John R. Sims MD Mark L. Urken MD 《Journal of surgical oncology》2019,120(8):1446-1449
Pharyngoesophageal stenosis (PES) is a common and serious complication of head and neck cancer treatments such as radiation therapy, chemotherapy, tracheoesophageal puncture placement, and total laryngectomy surgery. Dilation-resistant stenosis requires surgical reconstruction, often with a radial forearm free flap (RFFF). With the present technique, the authors refine their previous bipaddled free flap design used to reconstruct a persistent tracheoesophageal fistulae (TEF) in combination with PES. Accordingly, we present a novel bipaddled triangular RFFF design ideally suited to address the shape of the defect in the posterior tracheal wall that results when the TEF is opened and the esophageal and tracheal components are restored. 相似文献
2.
3.
Sumanta K. Pal MD Dean Bajorin MD Nazli Dizman MD Jean Hoffman-Censits MD David I. Quinn MD Daniel P. Petrylak MD Matthew D. Galsky MD Ulka Vaishampayan MD Ugo De Giorgi MD Sumati Gupta MD Howard A. Burris MD Harris S. Soifer PhD Gary Li PhD Hao Wang PhD Carl L. Dambkowski MD Susan Moran MD Siamak Daneshmand MD Jonathan E. Rosenberg MD 《Cancer》2020,126(11):2597-2606
4.
5.
6.
7.
8.
9.
Antonia K. Roseweir Jennifer Clark Stephen T. McSorley Hester C. vanWyk Jean A. Quinn Paul G. Horgan Donald C. McMillan James H. Park Joanne Edwards 《International journal of cancer. Journal international du cancer》2019,144(9):2320-2329
Tumour cell anaerobic metabolism has been reported to be a prognostic factor in colorectal cancer. The present study investigated the association between monocarboxylate transporter (MCT) 1, MCT 2, lactate dehydrogenase (LDH) 1 and LDH 5, the tumour microenvironment, and outcome in patients with colorectal cancer. A cohort of 150 patients with stage I-III CRC were utilised to assess tumour cell expression of MCT-1, MCT-2, LDH-1 and LDH-5 by immunohistochemistry. Expression levels were dichotomised and associations with tumour factors, the tumour microenvironment and survival analysed. Nuclear LDH-5 associates with poor prognosis (HR 1.68 95% CI 0.99–2.84, p = 0.050) and trends toward increased tumour stroma percentage (TSP, p = 0.125). Cytoplasmic MCT-2 also trends toward increased TSP (p = 0.081). When combined into a single score; nuclear LDH-5 + TSP significantly associated with decreased survival independent of stage (HR 2.61 95% CI 1.27–5.35, p = 0.009), increased tumour budding (p = 0.002) and decreased stromal T-lymphocytes (p = 0.014). Similarly, cytoplasmic MCT-2 + TSP significantly associated with decreased survival (HR 2.32 95% CI 1.31–4.11, p = 0.003), decreased necrosis (p = 0.039), and increased tumour budding (p = 0.004). The present study reports that the combination of TSP and nuclear LDH-5 was significantly associated with survival, increased tumour budding, and decreased stromal T-lymphocytes. This supports the hypothesis that increased stromal invasion promotes tumour progression via modulation of tumour metabolism. Moreover, MCT-2 and LDH-5 may provide promising therapeutic targets for patients with stromal-rich CRC. 相似文献
10.